Cargando…
microRNAs as Early Biomarkers of Alzheimer’s Disease: A Synaptic Perspective
Pathogenic processes underlying Alzheimer’s disease (AD) affect synaptic function from initial asymptomatic stages, long time before the onset of cognitive decline and neurodegeneration. Therefore, reliable biomarkers enabling early AD diagnosis and prognosis are needed to maximize the time window f...
Autores principales: | Siedlecki-Wullich, Dolores, Miñano-Molina, Alfredo J., Rodríguez-Álvarez, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827653/ https://www.ncbi.nlm.nih.gov/pubmed/33435363 http://dx.doi.org/10.3390/cells10010113 |
Ejemplares similares
-
Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease
por: Siedlecki-Wullich, Dolores, et al.
Publicado: (2019) -
Plasma microRNAs as potential biomarkers in early Alzheimer disease expression
por: Peña-Bautista, Carmen, et al.
Publicado: (2022) -
MicroRNAs as Candidate Biomarkers for Alzheimer’s Disease
por: Kanach, Colin, et al.
Publicado: (2021) -
Nr4a2 Transcription Factor in Hippocampal Synaptic Plasticity, Memory and Cognitive Dysfunction: A Perspective Review
por: Català-Solsona, Judit, et al.
Publicado: (2021) -
A new perspective on Alzheimer’s disease: microRNAs and circular RNAs
por: Abidin, Shahidee Zainal, et al.
Publicado: (2023)